Skip to main content
Clinical Trials/NCT05220254
NCT05220254
Completed
Not Applicable

Stanford Tobacco Treatment Services - Virtual Reality Treatment for Smoking Cessation

Stanford University1 site in 1 country20 target enrollmentOctober 18, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Smoking Cessation
Sponsor
Stanford University
Enrollment
20
Locations
1
Primary Endpoint
Number of Patients With Interest in the MindCotine Application
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study aims to see how feasible a mobile app based virtual reality program for smoking cessation (MindCotine) would be among Stanford cancer center patients

Registry
clinicaltrials.gov
Start Date
October 18, 2021
End Date
October 27, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Judith Prochaska

Professor of Medicine

Stanford University

Eligibility Criteria

Inclusion Criteria

  • Daily cigarette smoker or some day smoker (\>9 cigarettes per week)
  • English or Spanish fluent
  • Smartphone compatibility
  • Available to interact with a smartphone app for 6-weeks
  • Available to complete the EOT assessment at end of 6-weeks
  • Ability to understand and the willingness to personally sign the written IRB-approved informed consent document.
  • Confirm phone, email, address during consent

Exclusion Criteria

  • Ever had epilepsy
  • Less than 10 cigarettes per week
  • Not English or Spanish fluent
  • No smartphone compatibility
  • Unavailable to interact with the VR program,
  • Unavailable to answer questions about the intervention post-treatment

Outcomes

Primary Outcomes

Number of Patients With Interest in the MindCotine Application

Time Frame: 6 weeks

Total number of patients who expressed interest in the app, out of total number of participants who were screened for enrollment. This measure is to assess whether MindCotine is a feasible smoking cessation option among patients who smoke cigarettes.

Number of Patients Who Registered With the MindCotine Application

Time Frame: 6 weeks

Total number of patients who registered with the app, out of total number of participants who were enrolled (eligible and willing to accept help with quitting). This measure is to assess whether MindCotine is a feasible smoking cessation option among patients who smoke cigarettes.

Number of Patients Who Would Recommend the MindCotine Application as a Measure of Feasibility Among Patients Who Smoke.

Time Frame: 6 weeks

Learning whether MindCotine is a feasible smoking cessation option among patients who smoke cigarettes. Interest in using the app will be calculated as total number of patients who recommend the app to others.

Secondary Outcomes

  • Average Change in Cigarette Use(baseline to end of treatment, up to 6 weeks)
  • Number of Patients Who Attempt to Quit Smoking by Using the Application(6 weeks prior to end of treatment survey)
  • Number of MindCotine App Coaching Engagements Completed(6 weeks)
  • Number of MindCotine App Program Activities Completed(6 weeks)
  • MindCotine Dropout(6 weeks)
  • Number of Patients Using Cessation Medication by End of Treatment(6 weeks)
  • Number of MindCotine App Journal Entries Completed(6 weeks)

Study Sites (1)

Loading locations...

Similar Trials